Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients

Lawrence Harrison, Jiw K. Choe, Marsha Goldstein, Ara Meridian, Steve H. Kim, Kevin Clarke

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Background and Objectives: The purpose of this study is to examine the prognostic significance of immunohistochemical (IHC) evidence of lymph node (LN) metastases in histologic node negative gastric cancer patients. Methods: Retrospective review from 1981 to 1998 revealed 25 patients resected for T1- 4NOMO gastric and gastroesophageal (GE) junction adenocarcinoma. All cases were reviewed and histopathologic parameters were defined for each primary tumor. All LNs underwent IHC analysis with the epithelial marker CAM 5.2. Data are reported as median (range). Results: The median number of LN resected was 7 (range 1-33). The median follow-up time was 25 months (range 4-195) with an overall 5-year survival rate of 55%. For patients with IHC evidence of LN micrometastasis (n = 9), the 5-year survival rate was significantly decreased (35%) compared to a 66% 5-year survival rate for IHC negative patients (n = 16, P = 0.05). Conclusions: The presence of IHC- detected LN micrometastases correlates with worse prognosis for patients with histologic node negative gastric cancer. IHC may be a useful additional staging modality in this subset of patients. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)153-157
Number of pages5
JournalJournal of Surgical Oncology
Volume73
Issue number3
DOIs
StatePublished - Apr 7 2000
Externally publishedYes

Fingerprint

Neoplasm Micrometastasis
Stomach Neoplasms
Lymph Nodes
Survival Rate
Esophagogastric Junction
Stomach
Adenocarcinoma
Neoplasm Metastasis
Neoplasms

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Harrison, Lawrence ; Choe, Jiw K. ; Goldstein, Marsha ; Meridian, Ara ; Kim, Steve H. ; Clarke, Kevin. / Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients. In: Journal of Surgical Oncology. 2000 ; Vol. 73, No. 3. pp. 153-157.
@article{2103101f40e040cc99e583c6e8c53964,
title = "Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients",
abstract = "Background and Objectives: The purpose of this study is to examine the prognostic significance of immunohistochemical (IHC) evidence of lymph node (LN) metastases in histologic node negative gastric cancer patients. Methods: Retrospective review from 1981 to 1998 revealed 25 patients resected for T1- 4NOMO gastric and gastroesophageal (GE) junction adenocarcinoma. All cases were reviewed and histopathologic parameters were defined for each primary tumor. All LNs underwent IHC analysis with the epithelial marker CAM 5.2. Data are reported as median (range). Results: The median number of LN resected was 7 (range 1-33). The median follow-up time was 25 months (range 4-195) with an overall 5-year survival rate of 55{\%}. For patients with IHC evidence of LN micrometastasis (n = 9), the 5-year survival rate was significantly decreased (35{\%}) compared to a 66{\%} 5-year survival rate for IHC negative patients (n = 16, P = 0.05). Conclusions: The presence of IHC- detected LN micrometastases correlates with worse prognosis for patients with histologic node negative gastric cancer. IHC may be a useful additional staging modality in this subset of patients. (C) 2000 Wiley-Liss, Inc.",
author = "Lawrence Harrison and Choe, {Jiw K.} and Marsha Goldstein and Ara Meridian and Kim, {Steve H.} and Kevin Clarke",
year = "2000",
month = "4",
day = "7",
doi = "10.1002/(SICI)1096-9098(200003)73:3<153::AID-JSO8>3.0.CO;2-4",
language = "English (US)",
volume = "73",
pages = "153--157",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "3",

}

Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients. / Harrison, Lawrence; Choe, Jiw K.; Goldstein, Marsha; Meridian, Ara; Kim, Steve H.; Clarke, Kevin.

In: Journal of Surgical Oncology, Vol. 73, No. 3, 07.04.2000, p. 153-157.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients

AU - Harrison, Lawrence

AU - Choe, Jiw K.

AU - Goldstein, Marsha

AU - Meridian, Ara

AU - Kim, Steve H.

AU - Clarke, Kevin

PY - 2000/4/7

Y1 - 2000/4/7

N2 - Background and Objectives: The purpose of this study is to examine the prognostic significance of immunohistochemical (IHC) evidence of lymph node (LN) metastases in histologic node negative gastric cancer patients. Methods: Retrospective review from 1981 to 1998 revealed 25 patients resected for T1- 4NOMO gastric and gastroesophageal (GE) junction adenocarcinoma. All cases were reviewed and histopathologic parameters were defined for each primary tumor. All LNs underwent IHC analysis with the epithelial marker CAM 5.2. Data are reported as median (range). Results: The median number of LN resected was 7 (range 1-33). The median follow-up time was 25 months (range 4-195) with an overall 5-year survival rate of 55%. For patients with IHC evidence of LN micrometastasis (n = 9), the 5-year survival rate was significantly decreased (35%) compared to a 66% 5-year survival rate for IHC negative patients (n = 16, P = 0.05). Conclusions: The presence of IHC- detected LN micrometastases correlates with worse prognosis for patients with histologic node negative gastric cancer. IHC may be a useful additional staging modality in this subset of patients. (C) 2000 Wiley-Liss, Inc.

AB - Background and Objectives: The purpose of this study is to examine the prognostic significance of immunohistochemical (IHC) evidence of lymph node (LN) metastases in histologic node negative gastric cancer patients. Methods: Retrospective review from 1981 to 1998 revealed 25 patients resected for T1- 4NOMO gastric and gastroesophageal (GE) junction adenocarcinoma. All cases were reviewed and histopathologic parameters were defined for each primary tumor. All LNs underwent IHC analysis with the epithelial marker CAM 5.2. Data are reported as median (range). Results: The median number of LN resected was 7 (range 1-33). The median follow-up time was 25 months (range 4-195) with an overall 5-year survival rate of 55%. For patients with IHC evidence of LN micrometastasis (n = 9), the 5-year survival rate was significantly decreased (35%) compared to a 66% 5-year survival rate for IHC negative patients (n = 16, P = 0.05). Conclusions: The presence of IHC- detected LN micrometastases correlates with worse prognosis for patients with histologic node negative gastric cancer. IHC may be a useful additional staging modality in this subset of patients. (C) 2000 Wiley-Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0034063660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034063660&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9098(200003)73:3<153::AID-JSO8>3.0.CO;2-4

DO - 10.1002/(SICI)1096-9098(200003)73:3<153::AID-JSO8>3.0.CO;2-4

M3 - Article

VL - 73

SP - 153

EP - 157

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -